Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
137,162,201
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
2,071,200
-
Shares change
-
+324,128
-
Total reported value, excl. options
-
$1,687,992
-
Value change
-
+$173,028
-
Number of buys
-
20
-
Number of sells
-
8
-
Price
-
$0.8099
Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q1 2024
As of 31 Mar 2024 Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,071,200 shares of stock of the company.
Largest 10 holders included LUMINUS MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, JANE STREET GROUP, LLC, HRT FINANCIAL LP, BlackRock Inc., Verition Fund Management LLC, LPL Financial LLC, and Virtu Financial LLC.
This table shows 26 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.